We are live on ! Find out more
GYRE icon

Gyre Therapeutics

48 hedge funds and large institutions have $23.1M invested in Gyre Therapeutics in 2025 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 48 → 48 (0)

0% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 10

0.42% less ownership

Funds ownership: 3.64% → 3.21% (-0.42%)

19% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 16

71% less capital inflows, than outflows

Capital inflows: $973K | Capital outflows: $3.34M

Holders
48
Holders Change
–
Holders Change %
0%
% of All Funds
0.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
13
Reduced
16
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

GYRE Hedge Fund Activity: Q3 2025 in Review

48 of the 7,664 institutional investors tracked by Wall St. Rank reported a position in Gyre Therapeutics (GYRE) for Q3 2025, worth a combined $23.1M — down 7.9% from $25.1M a quarter earlier.

Fund positioning in GYRE was balanced in Q3 2025: 10 funds opened new positions, 10 closed out, 13 added to existing stakes and 16 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $271K. The largest seller was BlackRock, cutting an estimated $1.39M.

  • 48 institutional investors held Gyre Therapeutics (GYRE) as of Q3 2025, unchanged from Q2 2025.
  • Funds reported $23.1M of Gyre Therapeutics stock for Q3 2025, down 7.9% quarter-over-quarter.
  • 10 funds opened new Gyre Therapeutics positions in Q3 2025 and 10 closed out, a net change of 0 holders.
  • The largest Gyre Therapeutics buyer in Q3 2025 was Millennium Management, an estimated $271K added.
  • The largest Gyre Therapeutics seller in Q3 2025 was BlackRock, an estimated $1.39M sold.

Based on aggregated 13F filings for Q3 2025.